Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.

Not Applicable

Completed

• Conditions: Dry Eye Symptoms; Visual Performance
• Interventions: Other: Systane® Ultra

• Registration Number: NCT00938951
• Lead Sponsor: Alcon Research

Brief Summary

The primary objective of this study is to compare visual degradation in a stressed (forced stare) environment in patients before and after acute administration of Systane Ultra.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Study Start: 2009-06
• Primary Completion: 2009-07
• Study First Submitted: 2009-07-13
• Study First Submitted QC: 2009-07-13
• Study First Posted: 2009-07-14
• Status Verified: 2012-02
• Last Update Submitted: 2012-02-08
• Last Update Posted: 2012-02-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

• Player/ Coach must answer "Yes" to the survey eligibility question.
• Player/Coach must voluntarily agree to participate in survey

Read More

Exclusion Criteria

• None.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Systane® Ultra	Systane® Ultra	Systane® Ultra

Primary Outcome Measures

Name	Time	Method
Effectiveness of eye drop basd on athlete's opinion/experience during a one hour practice session	60 minutes post-dosing with test article